1-Minute Consult

Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?

Joy-Ann Tabanor, MBBS and Santhanam Lakshminarayanan, MBBS
Cleveland Clinic Journal of Medicine July 2019, 86 (7) 449-453; DOI: https://doi.org/10.3949/ccjm.86a.18084

Article Information

vol. 86 no. 7 449-453
DOI 
https://doi.org/10.3949/ccjm.86a.18084
PubMed 
31291178
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online July 1, 2019.
Copyright & Usage 
Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Joy-Ann Tabanor, MBBS⇑
  1. Fellow, Division of Rheumatology, University of Connecticut School of Medicine, Farmington, CT
  1. ADDRESS:
    Joy-Ann Tabanor, MBBS, Division of Rheumatology, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06030-5353; tabanor{at}uchc.edu
  1. Santhanam Lakshminarayanan, MBBS
  1. Chief, Division of Rheumatology, and Director, Rheumatology Fellowship Program, University of Connecticut School of Medicine, Farmington, CT

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects